Gene · 23495
TNFRSF13B: TNF receptor superfamily member 13B
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TNFRSF13B: TNF receptor superfamily member 13B. Genes, record 23495. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23495
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O14836 | Tumor necrosis factor receptor superfamily member 13B | 293 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents220
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026120702 A | 2026-07-22 | 88 | O14836 | Espacenet |
| US 12661386 B2 | 2026-06-23 | 10 | O14836 | Espacenet |
| US 12612447 B2 | 2026-04-28 | 88 | O14836 | Espacenet |
| EP 4705273 A2 | 2026-03-11 | 321 | O14836 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 68656 | O14836 | Espacenet |
| JP 2025540182 A | 2025-12-11 | 39 | O14836 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 234 | O14836 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1519 | O14836 | Espacenet |
| JP 2025535041 A | 2025-10-22 | 88 | O14836 | Espacenet |
| EP 4630445 A2 | 2025-10-15 | 39 | O14836 | Espacenet |
1 to 10 of 220
See all 220 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,652
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TNFRSF13B papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 11 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 10 | 2025 |
| UL1TR001866 | Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | 8 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 7 | 2025 |
| T32AI007512 | Molecular Basis of Allergic and Immunologic Disease | 7 | 2025 |
| T32AI055428 | Immune System Development and Regulation | 7 | 2025 |
| ZIAAI000646 | Transgenic Animal Models Of Human Immune Defects | 6 | 2025 |
| P01AI125180 | Plasma Cells in Health and Disease | 5 | 2025 |
| P01CA155258 | Integrative Oncogenomics of Multiple Myeloma | 5 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 5 | 2025 |
1 to 10 of 1,652Source NIH's project files
See all 1,652 nih grantsPapers2,649
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sustained clinical stability with telitacicept-containing maintenance therapy following glucocorticoid and IVIG induction for lupus enteritis with autoimmune hemolytic anemia: a case report. | Front Immunol | 2026 | 42780083 | PubTator, text mining | PubMed |
| BAFF and APRIL Receptors in B Cell Immunity and Autoimmunity. | Immunol Rev | 2026 | 42755123 | PubTator, text mining | PubMed |
Prevalence, associated clinical factors, and genetic characteristics of endocrinopathies in common variable immunodeficiency: a retrospective study of 95 adult patients from a single tertiary care center. | Front Immunol | 2026 | 42707139 | PubTator, text mining | PubMed |
| Toward Precision Oral Medicine in Pemphigus Vulgaris: A Conceptual AI Framework for Rituximab Response Prediction. | Pharmaceuticals (Basel) | 2026 | 42653788 | PubTator, text mining | PubMed |
| Clinical Heterogeneity of TNFRSF13B Variants: A Monogenic Cause or a Genetic Modifier? | Immunology | 2026 | 42601324 | PubTator, text mining | PubMed |
| BAFF and APRIL signaling in the B-cell lineage: implications for the pathogenesis of ANCA-associated vasculitis. | Front Immunol | 2026 | 42553115 | PubTator, text mining | PubMed |
| The Myeloma Risk Variant of TNFRSF13B Shows Reduced NF-κB Signalling Activity in HEK293 Cells. | Eur J Haematol | 2026 | 42548249 | PubTator, text mining | PubMed |
| Vaccine Responses in Early Age. | Vaccines (Basel) | 2026 | 42506666 | PubTator, text mining | PubMed |
| Balancing Act: The Dual Roles of BAFF in Systemic Lupus Erythematosus. | Drugs | 2026 | 42479350 | PubTator, text mining | PubMed |
| Telitacicept treatment for active antibody-mediated rejection after kidney transplantation: a case series. | J Nephrol | 2026 | 42475488 | PubTator, text mining | PubMed |
1 to 10 of 2,649
See all 2,649 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23495
GET https://conductscience.org/api/genes/v1/23495/patents?page=2